GSK Recalls Around 600,000 Ventolin Asthma Inhalers In The US

GlaxoSmithKline voluntarily recalled over 593,000 inhalers due to a defect in its packaging, which caused suspected propellant leakage. The company confirmed that this issue was not a direct threat to patients inhaling the product.